http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5063206-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 1989-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e54f15ab306a1b8174c18ee8822b46a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5e9f472487d4029b3567b97e313f378
publicationDate 1991-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5063206-A
titleOfInvention Compositions having use as treatment of neuropsychiatric deficits
abstract The present invention relates to methods of treating mental disorders and memory deficits not caused by HIV infection. The methods involve administration of a thymoleptic effective amount of defined linear peptides to patients. The peptides can be administered for example, as a powder or a solution obtained by dissolving a powder in a pharmaceutically acceptable solvent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5739109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002147129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7026280-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-671989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6242564-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9508338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807547-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9219257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5567682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5798335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5248667-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6320024-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5534495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10501494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510961-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9508339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973906-B2
priorityDate 1988-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0249394-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4659696-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4596795-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0249390-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129369570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395317

Total number of triples: 51.